Additional hits, perhaps in a particular order, in other cancer drivers, such as in the oncogene Catenin beta-1, and in the promoter region of telomerase reverse transcriptase [37,38,39] are probably required to confer differential selective advantages. The gene discussed is CTNNB1; the disease is cancer.